#510 - Todd Dunn, CEO at Accuryn Medical
Slice of Healthcare Team
07/14/2025
Guest
Connect via:
Todd Dunn is the Chief Executive Officer of Accuryn Medical, where he is leading efforts to reimagine kidney care through innovative solutions that improve patient outcomes and hospital efficiency. With a career spanning healthcare innovation, operations, and transformation, he has held leadership roles at Atrium Health, Intermountain Healthcare, Advocate Health, GE Healthcare, and McKesson. Todd is also the Founder of The Innovators Journey and has served as an Executive in Residence at the Scottsdale Institute. He holds an MBA in Supply Chain Management from Michigan State University and a B.S. in Marketing from the University of Utah.
Episode details
Join us on the latest episode, hosted by Jared S. Taylor!
Our Guest: Todd Dunn, CEO at Accuryn Medical.
What you’ll get out of this episode:
- Todd Dunn’s unique path: from healthcare innovator and Accuryn customer to CEO
- The enormous impact of acute kidney injury (AKI) in U.S. hospitals
- How Accuryn Medical digitizes kidney monitoring for earlier detection and intervention
- The financial and patient care benefits of automating kidney data and documentation
- Accuryn’s commitment to raising awareness and partnering with hospitals for better kidney outcomes.
Watch
Listen
Read More
Todd Dunn: From Healthcare Innovator to CEO
Todd Dunn’s career in healthcare innovation spans roles at McKesson, Siemens, GE, and leadership positions at Intermountain Healthcare and Atrium Healthcare. His journey with Accuryn Medical is unique: before becoming CEO, he was first a customer—someone who truly understood both the clinical problems and the business challenges hospitals face. That dual perspective now drives his leadership at Accuryn Medical.
The Hidden Crisis: Acute Kidney Injury
Each year, U.S. hospitals diagnose 3.4 million cases of acute kidney injury (AKI) using traditional methods, costing the industry $10–24 billion. The consequences for patients are dire: about 37% of those diagnosed with AKI in the hospital progress to chronic kidney disease. This not only impacts patients and families but also strains healthcare systems financially, driving up lengths of stay, readmission rates, and unnecessary escalations to dialysis—all of which affect hospital revenue and quality metrics.
Outdated Methods vs. Digital Innovation
Most hospitals still rely on a nearly 90-year-old technology—a gravity-fed Foley catheter—to monitor kidney function, making the process manual and prone to errors. As Dunn explains, while we digitize data for the heart, lungs, and brain in operating rooms and ICUs, kidney monitoring has been left behind.
Accuryn Medical changes this paradigm by digitizing the kidney. Their smart catheter automates urine output measurement and sends real-time data directly to the electronic medical record. This allows clinicians to receive early warnings of kidney distress—up to 12 hours before conventional blood tests can detect issues. The technology also provides alerts for acute kidney injury based on global standards, helping clinicians intervene sooner and prevent further deterioration.
Real Benefits: Financial and Clinical
Dunn encourages hospital leaders to assess their AKI documentation, analyze lengths of stay and readmission rates, and understand the true costs of under-documenting kidney injury. Accuryn’s automated system can not only improve patient outcomes but also reduce administrative burdens on clinical teams and help hospitals capture appropriate revenue by ensuring accurate, timely documentation.
What’s Next for Accuryn Medical?
Looking ahead, Accuryn Medical aims to build greater awareness about the clinical and financial harms of acute kidney injury. The company remains passionate about “protecting kidneys one patient at a time” and will continue partnering with healthcare systems to bring attention and innovation to this critical issue. As regulatory agencies begin to recognize AKI as a hospital harm, solutions like Accuryn’s are positioned to make an even bigger impact on patient safety and hospital performance.
